Lack of impact of platinum dose intensity on the outcome of ovarian cancer patients - 10-year results of a prospective randomised phase III study comparing carboplatin-cisplatin with cyclophosphamide-cisplatin

Author: Dittrich C.   Sevelda P.   Salzer H.   Obermair A.   Speiser P.   Breitenecker G.   Schemper M.   Kaider A.   on behalf of the Austrian Ovarian Cancer Study Group  

Publisher: Elsevier

ISSN: 0959-8049

Source: European Journal of Cancer, Vol.39, Iss.8, 2003-05, pp. : 1129-1140

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content